These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30744288)

  • 21. Vaccines against Neisseria meningitidis serogroup B strains - What does genomics reveal on the Portuguese strain's coverage.
    Bettencourt C; Nogueira P; Paulo Gomes J; João Simões M
    Vaccine; 2022 Aug; 40(33):4772-4779. PubMed ID: 35778280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland.
    Waśko I; Hong E; De Paola R; Stella M; Moschioni M; Taha MK; Skoczyńska A
    Vaccine; 2016 Jan; 34(4):510-515. PubMed ID: 26686998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular typing of group B Neisseria meningitidis'subcapsular antigens directly on biological samples demonstrates epidemiological congruence between culture-positive and -negative cases: A surveillance study of invasive disease over a 13-year period.
    Lodi L; Moriondo M; Nieddu F; Ricci S; Guiducci S; Lippi F; Canessa C; Calistri E; Citera F; Giovannini M; Indolfi G; Resti M; Azzari C
    J Infect; 2021 Apr; 82(4):28-36. PubMed ID: 33610687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland.
    Bodini M; Brozzi A; Giuliani M; Nohynek H; Vainio A; Kuusi M; De Paola R; Pizza M; Medini D; Toropainen M; Serino L; Muzzi A
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014-2017.
    Carannante A; Fazio C; Neri A; Lista F; Fillo S; Ciammaruconi A; Vacca P; Stefanelli P
    PLoS One; 2020; 15(11):e0241793. PubMed ID: 33176334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic surveillance of Neisseria meningitidis serogroup B invasive strains: Diversity of vaccine antigen types, Brazil, 2016-2018.
    de Lemos APS; Sacchi CT; Gonçalves CR; Camargo CH; Andrade AL
    PLoS One; 2020; 15(12):e0243375. PubMed ID: 33347452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meningococcal Antigen Typing System (MATS)-Based
    Rajam G; Stella M; Kim E; Paulos S; Boccadifuoco G; Serino L; Carlone G; Medini D
    mSphere; 2017; 2(6):. PubMed ID: 29152576
    [No Abstract]   [Full Text] [Related]  

  • 28. High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007-2011: Concordant predictions between MATS and genetic MATS.
    Tozer SJ; Smith HV; Whiley DM; Borrow R; Boccadifuoco G; Medini D; Serruto D; Giuliani MM; Stella M; De Paola R; Muzzi A; Pizza M; Sloots TP; Nissen MD
    Hum Vaccin Immunother; 2021 Sep; 17(9):3230-3238. PubMed ID: 33847225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway.
    Holst J; Comanducci M; Bambini S; Muzzi A; Comandi S; Oksnes J; DeTora L; Pizza M; Rappuoli R; Caugant DA
    Vaccine; 2014 May; 32(23):2722-31. PubMed ID: 24631075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine.
    Green LR; Lucidarme J; Dave N; Chan H; Clark S; Borrow R; Bayliss CD
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29950334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole genome sequence analysis of Neisseria meningitidis strains circulating in Kazakhstan, 2017-2018.
    Shevtsov A; Aushakhmetova Z; Amirgazin A; Khegay O; Kamalova D; Sanakulova B; Abdaliyev A; Bayesheva D; Seidullayeva A; Ramankulov Y; Shustov A; Vergnaud G
    PLoS One; 2022; 17(12):e0279536. PubMed ID: 36576937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp).
    Bettinger JA; Liberator P; Halperin SA; Vaudry W; Sadarangani M; Hao L; Lambert N; Jansen KU; Anderson AS; Tsang R;
    Vaccine; 2020 Feb; 38(8):2026-2033. PubMed ID: 31983586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines.
    Muzzi A; Bodini M; Topaz N; Masignani V; Vadivelu K; Marjuki H; Wang X; Serino L; Medini D
    mSphere; 2022 Oct; 7(5):e0038522. PubMed ID: 36129279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of serotyping antigens, clonal analysis and genetic characterization of the 4CMenB vaccine antigen genes in invasive Neisseria meningitidis from Western Canada, 2009 to 2013.
    Law DKS; Zhou J; Deng S; Hoang L; Tyrrell G; Horsman G; Wylie J; Tsang RSW
    J Med Microbiol; 2014 Nov; 63(Pt 11):1490-1499. PubMed ID: 25165123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).
    Bettinger JA; Scheifele DW; Halperin SA; Vaudry W; Findlow J; Borrow R; Medini D; Tsang R;
    Vaccine; 2013 Dec; 32(1):124-30. PubMed ID: 23588089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil.
    de Filippis I; de Lemos AP; Hostetler JB; Wollenberg K; Sacchi CT; Dunning Hotopp JC; Harrison LH; Bash MC; Prevots DR
    PLoS One; 2012; 7(3):e33016. PubMed ID: 22431994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic characteristics of Neisseria meningitidis serogroup B strains carried by adolescents living in Milan, Italy: implications for vaccine efficacy.
    Esposito S; Zampiero A; Terranova L; Montinaro V; Scala A; Ansuini V; Principi N
    Hum Vaccin Immunother; 2013 Nov; 9(11):2296-303. PubMed ID: 23880917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of a collection of Neisseria meningitidis isolates from Croatia, June 2009 to January 2014.
    Bukovski S; Vacca P; Anselmo A; Knezovic I; Fazio C; Neri A; Ciammaruconi A; Fortunato A; Palozzi AM; Fillo S; Lista F; Stefanelli P
    J Med Microbiol; 2016 Sep; 65(9):1013-1019. PubMed ID: 27452726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis.
    Murphy E; Andrew L; Lee KL; Dilts DA; Nunez L; Fink PS; Ambrose K; Borrow R; Findlow J; Taha MK; Deghmane AE; Kriz P; Musilek M; Kalmusova J; Caugant DA; Alvestad T; Mayer LW; Sacchi CT; Wang X; Martin D; von Gottberg A; du Plessis M; Klugman KP; Anderson AS; Jansen KU; Zlotnick GW; Hoiseth SK
    J Infect Dis; 2009 Aug; 200(3):379-89. PubMed ID: 19534597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development.
    Sacchi CT; Lemos AP; Popovic T; De Morais JC; Whitney AM; Melles CE; Brondi LM; Monteiro LM; Paiva MV; Solari CA; Mayer LW
    J Clin Microbiol; 2001 Aug; 39(8):2897-903. PubMed ID: 11474010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.